Trade

Mangalam Drugs And Organics share price

High risk
  • 50%Low risk
  • 50%Moderate risk
  • 50%Balanced risk
  • 50%High risk
  • 50%Extreme risk
  • ₹85.52(-0.23%)
    July 18, 2025 15:29:45 PM IST
    • NSE
    • BSE
  • Vol : 44.97K (NSE + BSE)
    Last 20 day avg : 66.82 K

Mangalam Drugs And Organics is trading -0.23% lower at Rs 85.52 as compared to its last closing price. Mangalam Drugs And Organics has been trading in the price range of 86.70 & 84.20. Mangalam Drugs And Organics has given -26.04% in this year & -4.03% in the last 5 days. Mangalam Drugs And Organics has TTM P/E ratio 17.48 as compared to the sector P/E of 25.87.The company posted a net profit of 0.06 Crores in its last quarter.Listed peers of Mangalam Drugs And Organics include Smruthi Organics (2.61%), Denis Chem Lab (0.85%), Mangalam Drugs And Organics (-0.23%).The Mutual Fund holding in Mangalam Drugs And Organics was at -% in . The MF holding has - from the last quarter. The FII holding in Mangalam Drugs And Organics was at 0.53% in 30 Jun 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Key Metrics

Updated on Jul 19, 2025, 11:25 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    0.90
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    19.96
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.19
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.60
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
84.20
Highest
86.70
52 week range
Lowest
65.50
Highest
144.65
Mangalam Drugs And Organics Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue fell during March quarter by 28.56% from Rs 102.24 crore to Rs 73.04 crore, year-on-year
    • financial-insightsThe company's profit declined by 98.33% year-on-year during the March quarter, dropping from Rs 3.55 crore to Rs 0.06 crore
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsEarnings are insufficient to cover the interest expenses on outstanding debt
Mangalam Drugs And Organics Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 95.28
  • R2
  • 109.69
  • R3
  • 124.58
Pivot80.39
  • S1
  • 65.98
  • S2
  • 51.09
  • S3
  • 36.68
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Mangalam Drugs And Organics Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Smruthi Organics
Bullish
127.902.61144.0340.702.021.1811.35
Denis Chem Lab
Moderately Bearish
100.650.85139.6717.251.642.490.53
Mangalam Drugs And Organics
Neutral
85.52-0.23136.1119.640.89-7.89
Parnax Lab
Moderately Bullish
108.500.88123.5910.151.41-31.58
Samrat Pharmachem
Moderately Bullish
370.50-1.67113.8115.201.510.29-
Mangalam Drugs And Organics Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Mangalam Drugs And Organics is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPledged found - Promoter(s) have pledged 13.23% of shares.
    • InsightsPromoter(s) have increased pledged shares to 11.01% from 13.23% earlier.
    • InsightsPromoter(s) holds a high stake in the company at 50.30%
    • InsightsPromoter(s) have decreased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 0.36 percentage points from previous quarter
    • InsightsMutual Funds are not invested in this company.
    Mangalam Drugs And Organics Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-17Audited Results
    2025-04-11Others
    2025-02-13Quarterly Results
    2024-11-14Quarterly Results
    2024-08-13Quarterly Results
    About the company Mangalam Drugs And Organics
    • IndustryBiotechnology & Drugs
    • ISININE584F01014
    • BSE Code532637
    • NSE CodeMANGALAM
    Mangalam Drugs and Organics Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Under the Company's Fight Malaria Program, it supplies anti-malaria APIs worldwide. Its products include API, intermediates and specialty chemicals. Its API products include acyclovir, amodiaquine, artemether, artesunate, atazanavir sulfate, bisoprolol fumarate, chloroquine phosphate, furosemide and dolutegravir sodium. The Company's intermediates products include 4,6-Dichloro-5-Methoxy Pyrimidine; 4,7- dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base, and tenofovir disoproxil base. Its specialty chemical products include L (+)-menthol; 2,3-dihydrophthalazine-1,4-dione or phthalazine-1,4-dione, and 4-cynoethyl-2-methyl phenol. Its pipeline APIs (under development) include Ganaplacide (IH), Tafenoquine Succinate (IH) and Pretomanid (IH). Its pipeline APIs (developed for research and development) is Bictegravir Na (IH).
    • Management Info
    • Govardhan DhootExecutive Chairman of the Board, Managing Director
    • Ajay SamantChief Financial Officer
    • Anuradha PandeyCompliance Officer, Company Secretary
    • Brijmohan DhootWhole-time Director
    Mangalam Drugs And Organics Share Price FAQs

    Mangalam Drugs And Organics is trading at 85.52 as on Fri Jul 18 2025 09:59:45. This is -0.23% lower as compared to its previous closing price of 85.72.

    The market capitalization of Mangalam Drugs And Organics is 136.11 Cr as on Fri Jul 18 2025 09:59:45.

    The 52 wk high for Mangalam Drugs And Organics is 144.65 whereas the 52 wk low is 65.50

    Mangalam Drugs And Organics can be analyzed on the following key metrics -

    • TTM P/E: 17.48
    • Sector P/E: 25.87
    • Dividend Yield: 0.00%
    • D/E ratio: 0.60

    Mangalam Drugs And Organics reported a net profit of 6.72 Cr in 2025.

    Quick Links
    EQUITY QUICK LINKS
    Mangalam Drugs And Organics QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   Mangalam Drugs And Organics share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.